Search Results

Management will host a conference call on Wednesday November 24, 2021, at 4:30 pm EDT to review financial Webcast / Conference Call Information: The live webcast of the conference call can be accessed online at https (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Chief of the Division of Clinical Neurophysiology and Epilepsy and Professor of Neurology at Harvard Medical (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most anavex.com Investors: Matthew Haines River East Investor Relations, LLC 917-733-9297 mhaines@rivereastir.com Media Dobson Media Group 203-258-0159 dennisdobsonjr@dobsonmediagroup.com Social Media: Bill Douglass Gotham

Anavex is utilizing innovative strategies in trial design in order to effectively and efficiently translate (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

Conference Call / Webcast Information Anavex will host a conference call and webcast today at 11:00 a.m The live webcast of the conference call can be accessed online at https://wsw.com/webcast/cc/avxl14. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

A live audio webcast will be available at https://wsw.com/webcast/cantor12/avxl.ob/2514820 or on the (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

drug will continue to benefit patients, Anavex will continue its responsibility to support patients post Therefore, post clinical studies, we are keen to provide supply to the investigators that have requested (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most Barwicki Investor Relations Tel: 516-662-9461 Email: andrew@barwicki.com [1] https://www.canada.ca/en

A webcast of the on-demand presentation will be available beginning Monday, September 13, 2021, at https (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

A live audio webcast will be available on https://www.webcaster4.com/Webcast/Page/2433/41061 or in the (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

A live audio webcast will be available on https://wsw.com/webcast/needham107/avxl/2271566 or in the Investors (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Phase 2 trial of ANAVEX®3-71 in schizophrenia ahead of schedule is a testament to the hard work and dedication homeostasis observed in individuals with schizophrenia, upstream of the targets leveraged by standard of care medications (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

organizes education and training and publishes a journal for healthcare practitioners, scientists and officials (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media

supplement and the accompanying prospectus may be obtained, when available, on the SEC’s website at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most